- 专利标题: Methods of identifying HIV patients sensitive to therapy with GP120 V3 glycan-directed antibodies
-
申请号: US16877292申请日: 2020-05-18
-
公开(公告)号: US12102677B2公开(公告)日: 2024-10-01
- 发明人: Brian Moldt , Craig S. Pace
- 申请人: Gilead Sciences, Inc.
- 申请人地址: US CA Foster City
- 专利权人: GILEAD SCIENCES, INC.
- 当前专利权人: GILEAD SCIENCES, INC.
- 当前专利权人地址: US CA Foster City
- 主分类号: A61K39/21
- IPC分类号: A61K39/21 ; A61K31/4745 ; A61K31/519 ; A61P31/18 ; C07K16/10 ; C12Q1/70
摘要:
Provided are methods for identifying patient populations infected with HIV that can be targeted by antibodies that bind to HIV gp120 V3 glycan region.
公开/授权文献
信息查询